Placental vascular pathology as a mechanism of disease in pregnancy complications.
about
Docosahexaenoic acid supplementation early in pregnancy may prevent deep placentation disorders.Placental vascular pathology and increased thrombin generation as mechanisms of disease in obstetrical syndromes.Angiogenic factors and uterine Doppler velocimetry in early- and late-onset preeclampsia.Placental lesions associated with acute atherosis.Type 1, type 2 and gestational diabetes mellitus differentially impact placental pathologic characteristics of uteroplacental malperfusion.Placental Complications and Bronchopulmonary Dysplasia: EPIPAGE-2 Cohort StudyMaternal HCV infection is associated with intrauterine fetal growth disturbance: A meta-analysis of observational studiesMild intrauterine hypoperfusion reproduces neurodevelopmental disorders observed in prematurityMaternal nutrition influences angiogenesis in the placenta through peroxisome proliferator activated receptors: A novel hypothesis.Ischemic placental syndrome--prediction and new disease monitoring.The association of maternal factors with epibulbar dermoid of newborn: a retrospective, matched case-control study.The structural and functional effects of fine particulate matter from cooking oil fumes on rat umbilical cord blood vessels.Retinol-Binding Protein 4 and Lipids Prospectively Measured During Early to Mid-Pregnancy in Relation to Preeclampsia and Preterm Birth Risk.Chronic hepatitis C virus infection is associated with increased risk of preterm birth: a meta-analysis of observational studies.Angiogenesis in the placenta: the role of reactive oxygen species signalingRisk factors for early postpartum hemorrhage (PPH) in the first vaginal delivery, and obstetrical outcomes in subsequent pregnancy.Chorangiomatosis: Evaluation of a placental vascular lesion and related clinical effects.Retained placenta is associated with pre-eclampsia, stillbirth, giving birth to a small-for-gestational-age infant, and spontaneous preterm birth: a national register-based study.Oligohydramnios is an independent risk factor for perinatal morbidity among women with pre-eclampsia who delivered preterm.Maternal carriers of the ANXA5 M2 haplotype are exposed to a greater risk for placenta-mediated pregnancy complications.Can prenatal screening reduce the adverse obstetric outcomes related to abnormal placentation?
P2860
Q33850028-E2531419-C84E-4E4F-894D-9451A37E18B7Q34568696-22A0C252-C115-4D2B-A4B1-9F60A5319E12Q35104545-5E541EA9-0978-4158-BB0F-A31A86E0655BQ35558666-5C6C2880-6B09-43BB-9794-CD4FDAA3D52CQ36173660-37BCD86D-A87A-4251-9FB8-C463F389DD31Q36630755-54472B39-BE6C-441C-A8D9-446AAE19ACE3Q37226463-AD63E7B2-C720-4922-BC6E-F37F8FA0C5DAQ37518955-A20E70B1-E6DA-4E4C-B9EA-A59B171EFEF4Q38534591-BEB05750-C02E-4C57-8B05-2E60F82FF793Q38601408-0DF02283-0059-4C74-89E9-EA691E6016C5Q38740443-3424272E-856F-4C17-8544-10E66DF6B26EQ38867389-7EE93D48-8A18-4D4D-8D3C-BB42644CB930Q38879727-6F03E009-FAD2-4109-9A98-A1B1C0B453C2Q38994989-B485A51D-099D-479A-B89C-72045B32CBE4Q41839328-7F96F013-0E1D-4116-944E-5CA56B25077FQ44692260-10CFD269-2F0A-45A9-B4E4-06A8E7880D07Q46218748-00CAAF4F-8C2D-426C-A4AB-C2100CBED05FQ47822335-CC58D87F-F108-4518-8906-604322D2CF36Q48123436-1E172064-ABAF-4283-B4B8-7E75A677C9F6Q52677785-10F0D729-DB0B-4888-BCDF-5042853DF2D1Q57316852-0566403E-650F-4F8A-A7D5-843DC99ACB1A
P2860
Placental vascular pathology as a mechanism of disease in pregnancy complications.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Placental vascular pathology as a mechanism of disease in pregnancy complications.
@en
type
label
Placental vascular pathology as a mechanism of disease in pregnancy complications.
@en
prefLabel
Placental vascular pathology as a mechanism of disease in pregnancy complications.
@en
P2093
P1433
P1476
Placental vascular pathology as a mechanism of disease in pregnancy complications.
@en
P2093
Letizia Schreiber
Michal Kovo
P304
P356
10.1016/S0049-3848(13)70013-6
P478
131 Suppl 1
P577
2013-01-01T00:00:00Z